Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 15, 2019
Tedor Pharma announced they entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine’s triple combination drug product for the short-term treatment of transient insomnia.
read more
Experic has announced the hire of Sherry Ann D’Iorio as executive director of business development.
read more
CombiGene signed an agreement with Cobra Biologics for production of candidate drug CG01.
read more
Thursday, October 10, 2019
MilliporeSigma has acquired FloDesign Sonics, developer of an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing.
read more
Wednesday, October 09, 2019
Aclaris announced the company, together with Allergan, has filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Taro.
read more
Tuesday, October 08, 2019
The doubled GMP production capacity enables Pepscan to shorten production timelines.
read more
Rentschler Biopharma SE will further develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation.
read more
Wednesday, October 02, 2019
Cellectis and Lonza announced the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates targeting hematological malignancies.
read more
Wednesday, October 02, 2019
LSNE announces approval of an ANDA from the FDA, for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.
read more
Monday, September 30, 2019
Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product candidates.
read more
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Wednesday, September 25, 2019
Catalent and Minerva Neurosciences have entered into a commercial supply agreement for roluperidone, an investigational compound from Minerva, for symptoms of schizophrenia.
read more
Wednesday, September 25, 2019
The FDA has announced a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz used to decrease the amount of acid created by the stomach.
read more
Tuesday, September 24, 2019
The Cell and Gene Therapy Catapult celebrates the completion of six additional modules at its manufacturing center in Stevenage.
read more